Funder Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Department of Defense  

$7,082,059.00
Fiscal Year: 2010

Download 2010 Department of Defense projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Immunopathogenesis in autism: Regulatory T cells and autoimmunity in neurodevelopment DeWitt, Jamie Q3.S.F East Carolina University
Improving synchronization and functional connectivity in autism spectrum disorders through plasticity-induced rehabilitation training Pineda, Jaime Q4.S.F University of California, San Diego
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders - 1 Lipton, Stuart Q4.S.B Burnham Institute
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders -2 Nakanishi, Nobuki Q4.S.B Burnham Institute
Intranasal oxytocin for the treatment of children and adolescents with autism spectrum disorders (ASD) Anagnostou, Evdokia Q4.S.C Holland Bloorview Kids Rehabilitation Hospital
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Ascherio, Alberto Q3.L.C Harvard University
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Santangelo, Susan Q3.L.C Massachusetts General Hospital
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Weisskopf, Marc Q3.L.C Harvard University
Mechanisms of mitochondrial dysfunction in autism Shoffner, John Q2.S.A Georgia State University
MeHG stimulates antiapoptotic signaling in stem cells Bressler, Joseph Q3.S.F Kennedy Krieger Institute
Modulation of fxr1 splicing as a treatment strategy for autism in fragile X syndrome Lin, Michael Q2.S.D Stanford University
Multiplexed suspension arrays to investigate newborn and childhood blood samples for potential immune biomarkers of autism Vogt, Robert Q1.L.A Centers for Disease Control and Prevention (CDC)
Neural basis of empathy and its dysfunction in autism spectrum disorders (ASD) Platt, Michael Q2.Other Duke University
Neural correlates of restricted, repetitive behaviors in autism spectrum disorders Manoach, Dara Q2.S.G Massachusetts General Hospital
Neural correlates of restricted, repetitive behaviors in autism spectrum disorders Santangelo, Susan Q2.S.G Massachusetts General Hospital
Novel probiotic therapies for autism Patterson, Paul Q4.S.B California Institute of Technology
Novel strategies to manipulate Ube3a expression for the treatment of autism and Angelman syndrome Roth, Bryan Q4.S.B University of North Carolina at Chapel Hill
Placental vascular tree as biomarker of autism/ASD risk Salafia, Carolyn Q1.L.A Research Foundation for Mental Hygiene, Inc.
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Pedersen, Cort Q4.S.B University of North Carolina at Chapel Hill
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Jarstfer, Michael Q4.S.B University of North Carolina at Chapel Hill
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Moy, Sheryl Q4.S.B University of North Carolina at Chapel Hill
Receptive vocabulary knowledge in low-functioning autism as assessed by eye movements, pupillary dilation, and event-related potentials Gordon, Barry Q1.L.C Johns Hopkins University
Redox abnormalities as a vulnerability phenotype for autism and related alterations in CNS development Hepel, Maria Q2.S.A State University of New York at Potsdam
Redox abnormalities as a vulnerability phenotype for autism and related alterations in CNS development James, Sandra Q2.S.A Arkansas Children's Hospital Research Institute
Redox abnormalities as a vulnerability phenotype for autism and related alterations in CNS development Noble, Mark Q2.S.A University of Rochester